Evidence map›Paper›PMID 15546539›Full record

ArticleAtencion primaria2004

[Characteristics of oral anti-coagulation treatment in high-risk chronic auricular fibrillation].

J L Clua Espuny, M R Dalmau Llorca, C Aguilar Martín, Grupo de Trabajo

2 registry-linked trialsOpen access · greenAbstract readEnglish AbstractMulticenter Study
In one paragraph

Article in Atencion primaria, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02273609 completednot on this mapstarted 2014, after this paper: background citation

English: Current Perspective of the Status of Anticoagulation in Clinical Practice in Primare Care. Spanish: Perspectiva Actual de la sitUación de la anticoaguLación en la práctica clínica de Atención Primaria.

TypeobservationalSponsorVivencio BarriosRan2014 to 2014Enrolled1,524ConditionsAtrial Fibrillation and FlutterArmsVitamin K antagonists (acenocoumarol or warfarin)
NCT03589170 unknown statusnot on this mapstarted 2016, after this paper: background citation

Atrial Fibrilation Opportunistic Screening and Stroke Incidence (AFOSS): Searching the Unknown Atrial Fibrillation.

Typeobservational_patient_registrySponsorFundacio d'Investigacio en Atencio Primaria Jordi Gol i GurinaRan2016 to 2019Enrolled51,410ConditionsAtrial FibrillationArmsOpportunistic atrial fibrillation screening
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

J L Clua EspunyTortosa 1 Est, Tortosa, Tarragona, Spain. jlclua.tarte.ics@gencat.net
M R Dalmau Llorca
C Aguilar Martín
Grupo de Trabajo
Hospital Universitari de Tortosa Verge de la Cinta · ESInstitut Català de la Salut · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo calculate the prevalence of chronic auricular fibrillation (CAF), how much of it is considered high-risk (CAFhr) and the degree of coverage with oral anti-coagulation treatment (OAT).

designMulti-centre descriptive study.

setting9 health districts. The "Terres de l'Ebre" Primary Care Service.

participantsRandomised sample of 375 patients with CAF, of whom 150 met the criteria of CAFh-r during 2002. MAIN MEASUREMENTS: Profile of patients with CAFh-r; coverage with OAT; place of follow-up; presence of vascular complications, and the time relationships between the diagnosis of CAF, vascular complications and the start of OAT. All the INR determinations taken from the patients included in the study were used.

resultsThere was 2.2% prevalence of CAF (95% CI, 1.4-3.3). 40% of CAF had criteria of CAFh-r. 74.2% were treated with OAT. In 41.7% the diagnosis of CAF coincided with the incidence of some vascular complication. There were no differences between the overall results of the INR obtained in hospital and in PC. The expected efficacy of OAT for thromboembolism prevention in our high-risk sample was 61.12%.

conclusions40% of the CAF are high-risk. In over a third of patients OAT was indicated after a vascular complication linked to an unknown CAF. The INR between 2-3 is similar in PC centres and the corresponding haematology service.

Indexed as

Drug Utilization ReviewAnticoagulantsAtrial FibrillationHumansInternational Normalized RatioPrevalenceRisk FactorsThromboembolismWarfarinAnticoagulantsWarfarin

Identifiers

PMID15546539
PMCPMC7668677
OpenAlexW2119414808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.